JAMA Editor’s Summary

Coordinated Care to Optimize Treatment in Patients With Diabetes and Cardiovascular Disease, Panitumumab vs Bevacizumab Added to Chemotherapy for Metastatic Colorectal Cancer, USPSTF Recommendation on Screening for Skin Cancer, and more

Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the April 18, 2023, issue. Related Content:

April 18, 2023

Listen on your favorite player Take me to this show’s page

Newer →

Bacterial Consortium Therapy for Prevention of Recurrent C diff Infection, 4-Factor Prothrombin Complex Concentrate in Patients With Trauma, Review of Pituitary Adenomas, and more

← Older

Heterogeneity in Blood Pressure Response to Antihypertensive Drugs, Renin-Angiotensin System Modulation for COVID-19, Review of Prediabetes, and more

Facebook Twitter Buffer LinkedIn WhatsApp

Coordinated Care to Optimize Treatment in Patients With Diabetes and Cardiovascular Disease, Panitumumab vs Bevacizumab Added to Chemotherapy for Metastatic Colorectal Cancer, USPSTF Recommendation on Screening for Skin Cancer, and more

Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the April 18, 2023, issue. Related Content: